(Q33364302)

26 July 2017

1 reference

title

Treatment of bipolar disorder: a systematic review of available data and clinical perspectives (English)

1 reference

26 July 2017

1 reference

1 reference

Eduard Vieta

2

0 references

author name string

Konstantinos N Fountoulakis

series ordinal

1

1 reference

26 July 2017

publication date

28 August 2008

1 reference

The International Journal of Neuropsychopharmacology

26 July 2017

published in

1 reference

26 July 2017

volume

11

1 reference

26 July 2017

issue

7

1 reference

26 July 2017

page(s)

999-1029

1 reference

A double-blind comparison of valproate and lithium in the treatment of acute mania

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Ultra short manic-like episodes after antidepressant augmentation with modafinil

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

The treatment of manic psychoses by the administration of lithium salts

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Forty years of lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Lithium-discontinuation-induced refractoriness: preliminary observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Valproate in the treatment of acute mania. A placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Episode sequence in bipolar disorder and response to lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Importance of Psychiatric Diagnosis in Prediction of Clinical Drug Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Incidence and significance of mixed affective states in a bipolar population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Self-Reported History of Manic/Hypomanic Switch Associated With Antidepressant Use

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Electroconvulsive treatment compared with lithium in the management of manic states

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Combined chlorpromazine and electroconvulsive therapy in mania

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Clozapine for treatment-refractory mania

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Impact of bipolar disorder on a U.S. community sample.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Carbamazepine in manic-depressive illness: a new treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

A randomized controlled trial of cognitive therapy for bipolar disorder: focus on long-term change.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

A Comparison of Lithium Carbonate and Chlorpromazine in Mania

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

A seven- year follow-up of an extremely refractory bipolar I patient.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Long-term effects of cognitive-behavioural therapy and lithium therapy on depression in the elderly

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Low-dose lithium augmentation of divalproex in geriatric mania

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomized, double-blind, controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

AACAP official action. Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Is response to prophylactic lithium a familial trait?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Screening for bipolar disorder in the community

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of risperidone monotherapy.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

An open-label study of amisulpride in the treatment of mania

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Typical and atypical antipsychotics in bipolar depression.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Experimental Withdrawal of Lithium in Recovered Manic-Depressive Patients: A Report of Five Cases

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

A controlled evaluation of lithium prophylaxis in affective disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Carbamazepine compared with lithium in the treatment of mania

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Psychoeducation efficacy in bipolar disorders: beyond compliance enhancement

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009231

7 January 2021

10.1017/S1461145708009231

Identifiers

DOI

1 reference

26 July 2017

1 reference